AngioDynamics to Report Fiscal 2013 Second Quarter Financial Results and Hold Conference Call on January 3, 2013

December 19, 2012 at 6:30 AM EST

ALBANY, N.Y., Dec. 19, 2012 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced that it will report its fiscal 2013 second quarter financial results on Thursday, January 3, 2013, after the close of the U.S. financial markets.

Management will host an investment community conference call beginning at 4:30 p.m. Eastern Time on January 3, 2013, to discuss the results and to answer questions.

To participate in the live call by telephone, please dial 1-877-941-0844.

Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of AngioDynamics' website at http://investors.angiodynamics.com. To listen to the live call, please go to the Web site 15 minutes prior to its start to register, download and install the necessary audio software. The conference call will also be archived on the website.

About AngioDynamics

AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at www.AngioDynamics.com.

Trademarks

AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary. 

CONTACT: Investor Relations Contacts:

         EVC Group, Inc.Jamar Ismail/Robert Jones

         (415) 568-9348; (646) 201-5447

         jismail@evcgroup.com;

         bjones@evcgroup.com



         Media Contact:

         EVC Group, Inc.Chris Gale

         (646) 201-5431

         cgale@evcgroup.com
Source: AngioDynamics

News Provided by Acquire Media